LA Law firm successfully represented a leading pharmaceutical company in a dispute with one of the largest Ukrainian distributors of pharmaceutical products, with claims totaling EUR 217,000. The case was heard by the International Commercial Arbitration Court at the Ukrainian Chamber of Commerce and Industry.
The client, a foreign company engaged in the production of pharmaceuticals, within the framework of a foreign economic contract supplied the Ukrainian distributor with several batches of goods for which the buyer failed to make payment.
After our arguments were presented, the distributor admitted the claims and proposed an amicable settlement. Our team conducted negotiations and secured a settlement agreement on terms favorable to the client.
We are pleased to have to have achieved a swift and cost-efficient victory for the client, while simultaneously expanding our experience in the field of cross-border debt recovery.
The project was handled by Partner Vitalii Savchuk, along with Senior Associate Yaroslav Furiaka and Associate Maksym Sulyma.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
